Form 8-K JOHNSON & JOHNSON For: Jul 16

Go back to Form 8-K JOHNSON & JOHNSON For: Jul 16

Johnson & Johnson (JNJ) PT Raised to $185 at Goldman Sachs

July 17, 2025 6:07 AM EDT

Goldman Sachs analyst Asad Haider raised the price target on Johnson & Johnson (NYSE: JNJ) to $185.00 (from $177.00) while maintaining a Buy rating.

The analyst comments "In a backdrop where we had that noted our investor conversations suggest sentiment shifting slightly more positive on the tactical setup for US pharma into 2Q earnings season (see: link), JNJ shares... More